Hypomania: how it differs from mania, and from simply feeling good

Short answer

Hypomania is a distinct episode of elevated or irritable mood with raised energy, lasting at least four consecutive days and clearly unlike your usual self. Mania is the same state pushed further: a week or longer, or severe enough to need hospital care. Psychosis makes it mania, never hypomania.

If people have told you this is just your personality, or you have spent years being treated for a depression that never quite lifted, you were not imagining the pattern. Hypomania is genuinely hard to spot from the inside — the state that needs attention is often the one that feels like finally being yourself.

If this started after an antidepressant was started, switched, or increased, tell the prescriber within days — and do not stop or lower the dose on your own.

Note: this article explains how clinicians tell these states apart and is not medical advice. Nothing here diagnoses bipolar disorder, and no app or wearable can. Sources are cited so you can read them yourself.

Hypomania vs mania at a glance: mania vs hypomania, side by side

Clinically, the first split is time plus severity. The milder-looking pole has to last at least 4 consecutive days to meet the usual episode-duration threshold; mania is framed as at least 1 week, or any length of time if the person needs hospitalization before a week has passed. But the calendar is only one part of the judgment. Clinicians also look at what the state does to your sleep, judgment, safety, relationships, work, spending, driving, sex, conflict, and ability to pause. (pubmed.ncbi.nlm.nih.gov)

In hypomania, other people may notice that you are not acting like your usual self — faster, more driven, more irritable, more talkative, sleeping less, taking on more, or seeming unusually “up.” The key clinical point is that the change is not severe enough to cause marked impairment, does not require hospitalization, and does not include psychosis. If delusions or hallucinations are part of the elevated or agitated mood state, clinicians do not count that as hypomania; that moves the episode into mania territory. (pmc.ncbi.nlm.nih.gov)

In mania, the nervous system is not just energized — it is harder to contain. The episode may seriously disrupt work, school, relationships, finances, sleep, or safety, and hospital-level care may be needed to prevent harm or stabilize the person. Psychosis can also appear during mania, which is one reason this distinction matters so much: treatment urgency and diagnosis can change. (pmc.ncbi.nlm.nih.gov)

The diagnostic direction is different, too. A history of a manic episode points clinicians toward bipolar I disorder. A pattern of hypomanic episodes plus major depressive episodes, with no history of mania, points toward bipolar II disorder. That does not mean you can sort it out from a checklist while you are in the middle of it. Clinicians usually need the timeline, medication history, substance use, sleep pattern, risk level, and often observations from people who know what your usual baseline looks like. (pmc.ncbi.nlm.nih.gov)

What clinicians actually look at

Clinicians do not look at one “happy” mood and call it an episode. They look for a cluster: a clear shift from your usual baseline in mood, energy, sleep, speed, activity, judgment, and behavior — strong enough that other people may notice it too. In bipolar mood episodes, the change is not just internal; it often shows up in how much you do, how fast you talk, how little you sleep, and how different you seem from yourself. (nimh.nih.gov)

Seven signals come up again and again:

• Sleep — sleeping much less and not feeling tired: reduced need for sleep, not insomnia with fatigue.

• Speed — racing thoughts, pressured speech others struggle to interrupt.

• Goal-directed activity — new projects, unusual productivity, activity that outstrips the plan.

• Judgment — spending, risk-taking, sexual or financial decisions out of character.

• Irritability — not every episode is euphoric; irritable, driven presentations are common and easy to miss.

• Timing — whether onset followed starting, switching, or increasing a medication.

• Other people — whether family, friends, or colleagues have remarked on the change.

Sleep is one of the big signals, but the detail matters. Clinicians listen for a reduced need for sleep — sleeping far less and still feeling charged or rested — not ordinary insomnia, where you cannot sleep and then feel exhausted. They also ask about speed: thoughts jumping, speech becoming hard to interrupt, ideas arriving faster than you can sort them, or other people saying they cannot keep up with you. (nimh.nih.gov)

They also look at drive. That can mean taking on new projects, working through the night, cleaning, messaging, planning, exercising, socializing, or pursuing goals with an intensity that outstrips the original plan. On the outside, it may look like productivity. Clinically, the question is different: is your brain and body accelerating in a way that is unusual for you, hard to slow down, and tied to poorer judgment or consequences? Increased goal-directed activity, pressured speech, decreased need for sleep, racing thoughts, and risk-taking are repeatedly described as core manic-spectrum signs. (pmc.ncbi.nlm.nih.gov)

Judgment is another place clinicians slow down. They ask about spending, sexual decisions, business ideas, driving, substance use, conflict, impulsive messages, or risks you would normally avoid. Not because any one choice proves anything, but because a pattern of “that was not like me” decisions can show that the elevated state is changing inhibition and threat assessment. (my.clevelandclinic.org)

The mood does not have to feel euphoric. Some episodes are irritable, wired, impatient, or angry — especially when the body is activated but the emotional tone is dark. That version is easy to miss because it can look like stress, burnout, anxiety, or “just being on edge,” but clinicians still pay attention to the same body-level signals: less sleep without tiredness, more speed, more activity, more impulsivity, and a noticeable change from baseline. (nimh.nih.gov)

Timing matters too. A clinician will ask whether the change began after starting a medication, increasing a dose, switching medications, adding supplements, using substances, or stopping something. If this is happening around an antidepressant or another psychiatric medication, do not stop it or lower the dose on your own — contact the prescriber who manages it. MedlinePlus warns not to change or stop antidepressants without provider help, and diagnostic guidance treats antidepressant-emergent mood elevation differently depending on whether symptoms fade with the medication’s physiological effect or persist beyond it. (medlineplus.gov)

Finally, clinicians often ask what other people have seen. Family, friends, partners, or colleagues may notice changes in activity, sleep, speech, irritability, confidence, or risk before you experience them as a problem. Their observations do not diagnose you either — but they help reconstruct the pattern, timeline, and degree of change. (nimh.nih.gov)

What hypomania is

Hypomania is a defined episode, not a mood, a personality trait, or a “good week.” In clinical use, it means a distinct stretch of abnormally elevated, expansive, or irritable mood that comes with abnormally increased activity or energy. Clinicians look for a change that is present most of the day, nearly every day, lasts at least four consecutive days, and is clearly different from how you usually function. Just as important: the change is not only something you feel inside. It is noticeable to other people — for example, in how fast you talk, how little sleep you seem to need, how many plans you start, how socially or sexually driven you become, or how unusually irritable and activated you are. (ncbi.nlm.nih.gov)

That “episode” part matters. There is a before and an after. A clinician is not trying to decide whether you are an upbeat person, an ambitious person, or someone who sometimes gets a burst of relief after depression. They are trying to reconstruct whether there was a bounded period when your mood and energy shifted away from your baseline in a way that others could see. A private sense of feeling better is not the same thing as hypomania; a change your partner, friends, family, or coworkers notice is a different kind of signal. That is the hypomania definition clinicians work from, and it is narrower than everyday usage: the hypomania meaning in a diagnostic conversation is a bounded episode with a start, a length, and consequences — not a temperament or a good stretch. (ncbi.nlm.nih.gov)

Hypomania also matters because of what it implies about the rest of the picture. The hallmark of bipolar disorder is hypomania or mania, and the predominant phase of illness is depression. (pmc.ncbi.nlm.nih.gov) That is why this pattern is so often missed: many people seek help when they are depressed, while the past episode that would change the diagnosis may be remembered as “I was finally myself again,” not as something clinically important. For bipolar II disorder in particular, the diagnostic picture depends on a history of both major depression and at least one hypomanic episode, which is one reason clinicians ask detailed questions about sleep, energy, behavior, and feedback from other people — not just about mood. (pmc.ncbi.nlm.nih.gov)

Hypomania vs mania: the line is severity and consequence

The symptom lists overlap almost completely: elevated or irritable mood, more energy, less need for sleep, faster thoughts or speech, distractibility, bigger plans, and riskier choices can appear in both. That is why searching manic vs hypomania for a separate symptom checklist can send you in the wrong direction. Clinically, “hypomania vs mania” is not mainly about which symptoms show up. It is about how long the state lasts, how far it changes your functioning, and whether it crosses into danger or psychosis. (ncbi.nlm.nih.gov)

Duration is one threshold. A hypomanic episode is counted in days — at least 4 consecutive days — while a manic episode is counted at a higher threshold: at least 1 week, unless hospitalization becomes necessary sooner. Function is another threshold. Hypomania means other people can see a clear, uncharacteristic change in how you operate, but the episode is not severe enough to cause marked social or work impairment or require hospitalization. Mania is different: the mood-and-energy shift is severe enough to markedly impair life, require hospitalization to prevent harm, or include psychotic features. If psychotic features are present, the episode is classified as manic, not hypomanic, regardless of duration. (ncbi.nlm.nih.gov)

That line is not a technicality. It changes which diagnosis a clinician can even consider: bipolar I disorder requires a manic episode, while bipolar II disorder involves hypomanic and major depressive episodes without a history of full mania. That distinction then changes the treatment conversation. It is also why this is not a call to make on your own. During an episode, the same brain systems pushing sleep down, speed up, confidence up, and brakes down can also make “I’m functioning fine” feel obvious from the inside — even when other people are seeing impairment from the outside. (ncbi.nlm.nih.gov)

Hypomania vs simply feeling better

This is the question people actually arrive with, especially after a long depressive episode or after starting treatment. Recovery can feel dramatic because depression was heavy: your body starts initiating again, decisions take less force, and ordinary tasks stop feeling like a wall. That alone is not the same as an episode.

Clinicians look for the shape of the change. Recovery usually moves you back toward yourself: your energy returns in a way that fits your life, sleep becomes more regular, your pace is easier to live with, and people close to you tend to feel relieved. Hypomania is more likely to overshoot. The body is not just “less depressed”; it may become unusually driven. Sleep shrinks while energy rises. Thoughts and speech can speed up. Plans multiply. Activity spills past what you meant to do. Judgment can shift before you can see the shift from the inside, which is why clinicians pay attention to what other people have noticed too. NIMH describes manic and hypomanic episodes as changes in mood, energy, and activity that are noticeable to others, with decreased need for sleep listed among the manic-episode symptoms. (nimh.nih.gov)

The most useful thing to track is often not the mood label, but sleep. Not “I slept badly and feel exhausted” — that can happen in anxiety, depression, stress, pain, and ordinary life. The more concerning pattern is: I slept much less than usual and still felt rested or unusually energized, for more than one night. Sleep changes are clinically important because decreased need for sleep is part of the symptom pattern clinicians assess in mania and hypomania; NICE also lists decreased need for sleep among the features that can support referral for specialist mental health assessment when overactivity or disinhibited behavior lasts several days. (nice.org.uk)

There is also research reason to take this seriously without turning it into a self-diagnosis rule. A systematic review of sleep changes before bipolar disorder found that decreased need for sleep may come before illness onset, especially before manic episodes, while insomnia is less specific because it can appear before either manic or depressive episodes. (pubmed.ncbi.nlm.nih.gov) So the practical takeaway is not “less sleep means you have hypomania.” It is: if you are sleeping markedly less, feel unusually energized anyway, and other people notice that your speed, risk-taking, irritability, spending, sexuality, talking, or plans are out of character, that pattern is worth reporting promptly and concretely.

If this began after starting or changing an antidepressant or another psychiatric medication, do not stop it, reduce it, or “test” yourself by changing the dose. Contact the prescriber and describe the sleep change, energy change, timing, and what others have noticed. NIMH notes that when subtle bipolar symptoms are missed, treating an initial depressive episode with an antidepressant alone may trigger mania or rapid cycling in some people. (nimh.nih.gov)

When the high mood starts after an antidepressant

This is one of the places where the honest answer is less soothing than the simple one.

If elevated mood, reduced need for sleep, faster thoughts, unusual confidence, impulsive plans, or a wired “I can’t slow down” feeling appears soon after starting an antidepressant, after a dose increase, or after switching drugs, a clinician has to hold two possibilities at once. One is a medication-related mood shift. The other is that bipolar illness was already there in the biology of your mood system, and the antidepressant made it visible. Those are not cleanly separable categories from the inside. Even in clinical practice, the question is not “was it the pill or was it you?” but: what exactly changed, how intense did it become, how long did it last, what else was happening in sleep and behavior, and did the episode keep going after the medication’s direct physiological effect should have worn off. A peer-reviewed clinical review summarizes the DSM-5 approach this way: if manic or hypomanic symptoms remain at a syndromal level after the antidepressant has been stopped and its physiological effects are no longer present, clinicians may count that as evidence for bipolar disorder rather than dismissing it as a transient drug effect. (pmc.ncbi.nlm.nih.gov)

That is why the antidepressant bipolar question — often searched as ssri-induced hypomania — is not really a “side effect or not?” question. “It was only the medication” is not an all-clear. Sometimes symptoms that fade quickly after a medication change may fit a substance- or medication-induced picture. But a full episode that outlasts the drug effect changes the diagnostic conversation. It can change the whole treatment plan, not just the prescription.

The research picture is also not simple, which is exactly why this belongs with the prescriber. A 2025 network meta-analysis of acute antidepressant treatment for bipolar depression included 13 randomized trials and 1,362 people; trial duration averaged 6.9 weeks and ranged from 1.7 to 10 weeks. It did not find any individual antidepressant with a statistically significant higher switch-to-mania risk than placebo, but venlafaxine had the highest risk estimate and was the only drug with consistent switch signals across individual studies; the authors rated the overall certainty of evidence as low. (pubmed.ncbi.nlm.nih.gov) Naturalistic data look different: one systematic review reported treatment-emergent mania or hypomania in bipolar disorder ranging from 17.3% to 48.8%, with switches more frequent when antidepressants were used alone than when they were combined with mood stabilizers, especially lithium, or second-generation antipsychotics. (pubmed.ncbi.nlm.nih.gov) And a large 2025 real-world study across five databases found an overall switch prevalence of 5.2% over a 730-day window and no significantly higher switch risk in people prescribed antidepressants compared with those not prescribed antidepressants after adjustment. (pmc.ncbi.nlm.nih.gov)

So the point is not panic. It is precision. Trial data, clinic data, and real-world records do not all tell the same story because they are looking at different people, different risk levels, different definitions, and different time windows. The thing your clinician needs from you is the timeline: when the medication started, when the dose changed, when sleep changed, when other people noticed you were not yourself, whether spending, sex, driving, substances, work, messages, or conflict escalated, and whether the “high” kept going after the medication was changed or stopped under medical supervision.

That this is a live clinical dilemma rather than a rare curiosity is stated plainly in the trial literature: This creates a clinical dilemma whereby the administration of first-line antidepressants (e.g., sertraline) for anxiety is debated in patients with a bipolar diathesis, given the associated risk of mood destabilization. (pmc.ncbi.nlm.nih.gov) The same paper lists what makes that risk higher: Established clinical high-risk factors include early onset, family history of BD, and subthreshold manic symptoms. (pmc.ncbi.nlm.nih.gov) Those three are worth knowing because they are things you can tell a clinician about yourself: whether mood problems began young, whether bipolar disorder runs in your family, and whether you have ever had shorter or less obvious periods of elevated energy, reduced sleep, or unusually driven behavior before.

Other risk signals also matter. In a prospective study of 221 depressed bipolar I and II patients treated with antidepressants added to mood stabilizers or atypical antipsychotics, 24.4% had a treatment-emergent switch into hypomania, mania, or mixed states within 8 weeks of starting or increasing an antidepressant; earlier age at onset, previous switches, and lower response to antidepressants were associated with higher risk. (pubmed.ncbi.nlm.nih.gov) A broader clinical review also notes that previous antidepressant-induced mania, bipolar family history, and exposure to multiple antidepressant trials are among the most consistently supported risk factors. (pubmed.ncbi.nlm.nih.gov)

And the thing not to do: do not stop or reduce the antidepressant on your own because you suspect this. Stopping abruptly can cause antidepressant discontinuation symptoms — commonly flu-like feelings, insomnia, nausea, dizziness or imbalance, sensory “electric shock” sensations, anxiety, irritability, or agitation — and it can make the clinical picture harder to read. (pmc.ncbi.nlm.nih.gov) If bipolar illness is underneath, unmanaged medication changes can destabilize mood further. The move is to contact the prescriber quickly — days, not weeks — and say, plainly: “My sleep, energy, speed, and behavior changed after this medication change. I’m worried this could be a switch.”

Why bipolar II is often treated as depression for years

Because depression is usually what hurts enough to bring you into care. It is heavy, frightening, disruptive. It stops work, sleep, appetite, relationships, and basic self-trust. Hypomania can do the opposite on the surface: more energy, less sleep, more plans, more talking, more speed. After months of flatness, that may read as “I’m finally better,” not “this is part of the pattern.” So it may never be mentioned. And if the clinician only hears about the lows, they are missing the half of the illness that would change the diagnostic conversation. NIMH notes that people with bipolar II may seek help only for depressive episodes, while hypomanic episodes can go unnoticed. (nimh.nih.gov)

That is why the delay can be long, especially in bipolar II. In the HOPE-BD study, the median delay between a first mood episode and the correct bipolar diagnosis was 5.0 years for bipolar I and 11.0 years for bipolar II. Another study of people first diagnosed with depression and later diagnosed with bipolar disorder found a mean delay of 8.74 years before diagnostic conversion. (pubmed.ncbi.nlm.nih.gov)

The overlap makes it harder still. Diagnosis can be challenging due to symptom overlap with attention-deficit hyperactivity disorder, major depressive disorder, psychotic spectrum disorders, and personality disorders, which often leads to a delay in diagnosis. The same review emphasizes that depression is often the predominant phase of bipolar illness, which helps explain why the condition can look, at first contact, like depression alone. (pmc.ncbi.nlm.nih.gov)

The scale is not small either: bipolar disorder affects approximately 40 million individuals worldwide and carries increased mortality from suicide and other causes. This is not just a naming problem. When bipolar depression is treated as unipolar depression for years, the person may miss the kind of assessment and treatment planning that fits the whole mood pattern, including elevated or unusually energized states. (pmc.ncbi.nlm.nih.gov)

The practical consequence for a reader: if you have been treated for depression and have ever had a stretch of days when you needed much less sleep, felt unusually driven or wired, talked more, took on more than usual, or other people noticed you seemed unlike yourself, that stretch belongs in the conversation with your clinician — even if it felt like the good part. It does not prove bipolar II on its own. It is context your clinician needs. That stretch is what clinicians mean by bipolar hypomania, and it is the piece most often missing from the record. (nimh.nih.gov)

Mixed features: the state to take most seriously

Elevated and depressive symptoms can happen in the same episode. Your body may feel switched on — driven, restless, irritable, unable to sleep — while your mind stays dark, hopeless, guilty, or preoccupied with death. Clinicians call this a mixed presentation or an episode with mixed features. It matters because the “up” part can add energy, speed, and impulsivity to a depressive state, which is one reason this pattern is treated as higher-risk than a simple good mood or ordinary restlessness. Research in bipolar disorder links mixed features with suicidal behavior, and reviews advise clinicians to pay close attention to suicide risk when manic and depressive symptoms overlap. (pubmed.ncbi.nlm.nih.gov)

This is also one of the states that can be misread from the inside as “maybe the medication is working, just roughly” or “maybe I’m finally getting energy back.” But if energy, agitation, pacing, racing thoughts, or sleeplessness are rising while mood stays bleak — especially if thoughts of death, self-harm, or feeling unable to keep yourself safe are present — do not wait to “see how it goes.” Seek care the same day. If this started after a prescribed antidepressant or another psychiatric medication change, do not stop it or lower the dose on your own; contact the clinician who prescribed it urgently, because that distinction changes treatment.

How to bring this up with your doctor

The distinction is theirs to make, but you can make the clinical picture easier to see. Bring a simple timeline, not a polished explanation. Write down when the change started; what happened with medication just before it — a new prescription, dose increase, switch, missed doses, or stopping and restarting; and what changed in your sleep, energy, behavior, and judgment. If a medication change seems connected, don’t stop it or lower the dose on your own — contact the prescriber and bring the timeline to them.

Put sleep near the top. Not just “bad sleep” or “barely slept,” but hours per night, several nights in a row, and whether you felt tired the next day. Clinicians pay close attention to decreased need for sleep, especially when it appears alongside higher energy or activity, because that pattern is part of how manic and hypomanic episodes are assessed. They also look at duration and whether the change is clearly different from your usual functioning. (ncbi.nlm.nih.gov)

Add what other people noticed, as close to their actual words as you can: “you’re talking too fast,” “you’re not acting like yourself,” “you spent a lot,” “you started three things and couldn’t stop.” That is not gossip. Outside observation can be clinically important because hypomanic symptoms may be more visible to partners, family, friends, or coworkers than they feel from the inside. (pmc.ncbi.nlm.nih.gov)

Write down function, not just mood. What did you do differently? Projects started, money spent, risks taken, sexual or social choices that were out of character, conflicts, driving, substance use, messages sent, work decisions, promises made. Then write duration in consecutive days, not “recently.” If you can, add personal and family history: early mood problems, repeated depressions, hospitalizations, suicide attempts, psychosis, or bipolar disorder in blood relatives. Diagnosis is based on the length, severity, frequency, and lifetime pattern of symptoms, plus family history — not on one good day or one screening score. (nimh.nih.gov)

Written notes beat memory. Even structured recall of manic symptoms over the previous 3 months missed some symptom weeks in research, and retrospective mood reporting is especially vulnerable to recall bias. A dated note made close to the time gives your clinician a cleaner signal than trying to reconstruct everything after your sleep, mood, and energy have already shifted. (pmc.ncbi.nlm.nih.gov)

A wearable or phone can help with exactly one part of this: it can show sleep duration and activity over time, which is the objective half of the picture. It cannot detect hypomania, and no app or questionnaire can diagnose it. Digital tools can capture sleep, activity, mobility, and other signals, but evidence linking those signals reliably to specific bipolar mood states is still inconclusive; screening tools can support a more careful clinical interview, not replace one. (pmc.ncbi.nlm.nih.gov)

Do not stop the antidepressant on your own

There are two separate reasons, and both matter.

First, stopping suddenly can make your nervous system react. Clinicians call this antidepressant discontinuation syndrome: a cluster of symptoms that may include dizziness or light-headedness, nausea, vertigo, nervousness or irritability, sleep disruption, flu-like feelings, restlessness, agitation, and odd sensory sensations — including electric-shock-like feelings sometimes described as “brain zaps.” In a 2025 systematic review and meta-analysis of 50 studies with 17,828 participants, people who stopped antidepressants had, on average, 1 more symptom on a discontinuation-symptom scale at 1 week than people who continued medication or stopped placebo. In placebo-controlled studies, dizziness or light-headedness was the most frequent specific symptom: 7.50% after antidepressant discontinuation vs 1.82% after placebo discontinuation, with a risk difference of 6.24%. Nausea was 4.11% vs 1.49%, with a risk difference of 2.90%. NICE also lists withdrawal symptoms such as dizziness, nausea, sleep problems, agitation, irritability, anxiety, low mood, and altered sensations including electric-shock sensations, and notes that symptoms may appear within a few days of reducing or stopping medication and can be more severe when the medicine is stopped suddenly. (pmc.ncbi.nlm.nih.gov)

Second, withdrawal can blur the exact picture your clinician needs to understand. Agitation, insomnia, irritability, nervousness, and low mood after a sudden stop can look like the thing you were worried about. And the reverse can also happen: an emerging mood episode can be mistaken for withdrawal. That is one reason stopping on your own is not a neutral experiment. It removes the timeline your prescriber needs — what changed, when it changed, and whether symptoms followed missed doses, dose reduction, medication effects, or a developing episode.

The right sequence is boring because it protects you: keep taking the antidepressant exactly as prescribed, contact the person who prescribed it, and let any dose change be planned. A systematic review of 21 major clinical practice guidelines found that 15 guidelines — 71% — recommended gradual or slow tapering, although they often gave limited practical detail on exact dose reductions or how to separate withdrawal from relapse. NICE is more explicit: if someone is stopping an antidepressant, the dose is usually reduced in stages over time, the speed and duration should be agreed with the healthcare professional, and the next reduction should wait until withdrawal symptoms have resolved or are tolerable. (pubmed.ncbi.nlm.nih.gov)

How fast is “safe” is not something to guess from the internet, because the drug matters and your history matters. In a small randomized study of 28 people switching from an SSRI or venlafaxine, discontinuation syndrome occurred in 46% overall and was similar after a 3-day taper and a 14-day taper, but people stopping shorter half-life antidepressants had greater increases in discontinuation and depressive symptoms than those stopping fluoxetine. NICE similarly says the pharmacokinetic profile matters, and that short half-life antidepressants — including paroxetine and venlafaxine — may need particular care. (pubmed.ncbi.nlm.nih.gov)

So if you think the antidepressant is pushing your mood upward, making sleep feel unnecessary, increasing agitation, or otherwise changing you in a way that worries you, do not stop it or lower the dose yourself. Keep taking it as prescribed and contact the prescriber promptly. If tapering, switching, holding the dose, or urgent review is needed, that plan should be made by someone who can watch what happens next.

When to seek help now

Some situations do not wait for the next appointment. If you are thinking about suicide or self-harm, feel that you might act on those thoughts, or someone may be in immediate danger, get help now: in the U.S., call or text 988 for crisis support, and call 911 or go to the nearest emergency room if the danger is immediate or life-threatening. (samhsa.gov)

Seek urgent care the same day if you have gone several days with almost no sleep and cannot slow down; if you are hearing or seeing things other people do not, or holding beliefs that people close to you find frightening; or if fast-moving decisions are putting your body, money, job, relationships, or safety at risk — for example, reckless driving, unsafe sex, quitting suddenly, or spending large sums. These are not “just personality” questions; they are signs clinicians treat as safety issues. (my.clevelandclinic.org)

Also do not wait if agitation is rising while your mood stays dark: the body is activated, sleep may be breaking down, thoughts may speed up, but the emotional background can still be hopeless or desperate. Mixed depressive-and-activated states are associated with higher suicidal behavior than “pure” mania or hypomania, so this is a today problem, not a “see how the next two weeks go” problem. (pubmed.ncbi.nlm.nih.gov)

And take it seriously if someone close to you says they are scared by the change. During mood episodes, shifts in energy, behavior, sleep, judgment, and activity level are often more visible from the outside than they feel from the inside. If you are unsure whether it counts as urgent, let that uncertainty be the reason to call, not the reason to wait. (nimh.nih.gov)

How Welltory helps — and what it cannot do

Start with the limit, because it is the important part. Welltory does not detect hypomania, does not screen for bipolar disorder, and cannot tell you whether a change in your state is an episode. No consumer app can. It is a general wellness product with no regulatory clearance, and the assessment in this article belongs to a clinician.

What it can do is hold the one piece of evidence that is hardest to reconstruct afterwards: your sleep, night after night, in numbers. The cardinal sign clinicians ask about is a reduced need for sleep — four or five hours and no tiredness the next day — and that is precisely the detail memory distorts. In the moment it does not feel like a symptom; it feels like efficiency. Weeks later, "I think I was sleeping less?" is worth very little in an appointment. A row of nights with hours on them is worth a great deal.

The same applies to what surrounds it. Resting heart rate and heart rate variability shift when the body is running hot, and having your own months-long baseline is what makes a two-week stretch legible as unusual for you rather than unusual in general. That comparison is the whole value — not a score, not an alert, not a label.

So the honest role is narrow: Welltory is a record, not a verdict. Bring the record. Let the clinician read it.

What hypomania is not

It is not a personality type. It is not ambition, charisma, a creative streak, or “finally becoming your best self.” Clinicians are not looking for whether you are energetic by nature; they are looking for a clear shift from your usual baseline — in mood, energy, activity, sleep, speech, risk-taking, or irritability — and whether other people can notice that shift too. (nimh.nih.gov)

It is also not the same as simply feeling better on treatment. Feeling steadier, sleeping more normally, and getting life back after depression can be recovery. A hypomanic episode is different because the body’s activation rises in a way that is uncharacteristic for you: less need for sleep, more drive, faster thoughts, more talking, more plans, more spending or risk, more friction with people — sometimes with a feeling that nothing is wrong. (nimh.nih.gov) If this kind of change appears after starting or changing an antidepressant or another psychiatric medication, do not stop it or lower the dose on your own; contact the clinician who prescribed it.

And it is not something an app, a quiz, or a page like this one can establish about you. The useful role of tracking is narrower and safer: write down what changed, when it started, how much you slept, what other people noticed, what medications or substances were involved, and whether the change is creating consequences. Then bring that pattern to someone who can evaluate it in context and act on it. The word that does the work here is change.

How we made it

Made with AI tools, then edited, fact-checked and medically reviewed by the Welltory team. See our Editorial & AI policy.

Data analysis by Jane Smorodnikova, co-founder of Welltory and the person who built the methodology behind how we read physiological data.

Written by Kseniia Iaroslavtseva.

Reviewed by Anna Elitzur — Medical Advisor & Mental Health Expert.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data